Butterfly Network Reports Tomorrow After Breaking Even on Cash but Not on Proof

Butterfly Network (BFLY) reports first-quarter 2026 earnings before the market opens on April 30, 2026, with analysts expecting a loss of $0.06 per share. The medical imaging innovator faces a critical test as investors weigh recent FDA clearances and strategic appointments against a volatile earnings track record that has seen the stock swing dramatically—including a +50.65% surge following its last report. With the stock trading at $4.92 and analysts maintaining a 100% Buy signal, the question is whether BFLY can sustain momentum from its breakthrough AI gestational age tool and deliver on its promise to democratize ultrasound technology.

Part 1: Earnings Preview

Butterfly Network is a healthcare technology company pioneering semiconductor-based ultrasound devices through its proprietary Ultrasound-on-Chip™ platform, combining handheld imaging hardware with cloud-based AI software to democratize medical imaging globally. The company's flagship products—the Butterfly iQ series—enable whole-body ultrasound scanning via handheld probes connected to smart devices, targeting hospitals, clinics, and point-of-care settings worldwide.

For the first quarter ending March 31, 2026, analysts expect BFLY to report a loss of $0.06 per share on revenue of approximately $24.75 million. The company most recently reported fourth-quarter 2025 earnings of -$0.05 per share, beating estimates by $0.01 and delivering revenue of $31.51 million—19.17% above expectations. Year-over-year, the Q1 2026 estimate represents a 33.33% improvement from the $0.09 loss reported in Q1 2025, signaling continued progress toward profitability.

Three key themes define this earnings story:

FDA Clearance Momentum: On March 30, 2026, Butterfly secured its first FDA clearance for a blind-sweep ultrasound AI tool—an automated Gestational Age (GA) Tool that estimates pregnancy progression in minutes. This marks a significant milestone as the first FDA-cleared AI tool of its kind, directly addressing critical maternal and fetal health challenges. The clearance validates Butterfly's AI capabilities and opens substantial market opportunities in women's health, a segment where timely diagnostic information can reduce mortality rates. Investors will scrutinize whether this breakthrough translates into accelerated adoption and revenue growth.

Strategic Innovation Leadership: The March 7, 2026 appointment of David Horsley—co-founder of Chirp Microsystems—as Senior Vice President of Innovation for Butterfly Embedded™ signals an aggressive push to expand the company's platform strategy beyond handheld devices. Horsley's expertise in ultrasonic sensing and MEMS technology suggests Butterfly is positioning to embed its chip technology into third-party medical devices, potentially creating new revenue streams and expanding total addressable market. The timing of this hire ahead of earnings suggests management confidence in the embedded strategy's near-term potential.

Profitability Path and Operational Efficiency: With losses narrowing from $0.09 in Q1 2025 to an expected $0.06 in Q1 2026, and full-year 2026 estimates projecting a $0.19 loss (improving 9.52% from 2025), the trajectory toward breakeven remains the overarching narrative. Analysts upgraded full-year estimates from $0.21 to $0.19, reflecting growing confidence in operational leverage. However, the company's negative 79% profit margin and -35.3% return on equity underscore that profitability remains distant. Investors will focus on gross margin trends, operating expense discipline, and whether the FDA clearance accelerates the path to positive cash flow.

Analyst commentary ahead of the release reflects cautious optimism. Craig Hallum maintains a Buy rating with a $3.00 target, while William Blair holds an Outperform rating. The consensus among 6 analysts shows 5 Strong Buys and 1 Hold, with a mean price target of $5.56—implying 13% upside from current levels. However, Oppenheimer's August 2025 downgrade from Outperform to Perform highlights lingering concerns about execution risk and the timeline to profitability despite technological achievements.

Part 2: Historical Earnings Performance

Butterfly Network has demonstrated a strong tendency to beat earnings estimates, surpassing consensus in 6 of the last 8 quarters tracked. The magnitude of beats has been meaningful, with surprises ranging from +14.29% to +33.33% in recent quarters. Most notably, Q1 2025 delivered a $0.06 loss versus the $0.09 estimate (+33.33% beat), Q2 2025 posted $0.06 against $0.07 expected (+14.29%), and Q4 2025 came in at $0.05 versus $0.06 consensus (+16.67%).

The pattern reveals improving execution consistency after a significant Q3 2025 stumble, when BFLY reported a $0.13 loss against a $0.07 estimate—an -85.71% miss that stands as a clear outlier. That quarter's underperformance appears to have been an anomaly rather than a trend reversal, as the company immediately returned to form with a beat in Q4 2025. The sequential improvement from $0.13 in Q3 to $0.05 in Q4 suggests management successfully addressed whatever operational challenges emerged mid-year.

The longer-term trajectory shows steady progress toward profitability, with reported losses compressing from $0.21 in Q4 2023 to $0.05 in Q4 2025. This consistent narrowing of losses—despite the Q3 2025 setback—indicates operational leverage is building as the company scales. Given this track record, investors should reasonably expect BFLY to meet or modestly exceed the $0.06 consensus estimate for Q1 2026, barring any unexpected headwinds.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Butterfly Network reports earnings before market open, meaning Day 0 captures the market's immediate reaction during the first trading session after results are released, while Day +1 reflects follow-through momentum.

BFLY exhibits extreme volatility around earnings announcements, with an average absolute Day 0 move of 15.96% and Day 0 range of 19.52%—far exceeding typical market reactions. The most recent report on February 26, 2026 exemplifies this pattern: the stock surged 50.65% on Day 0 following the earnings beat, then pulled back -18.84% on Day +1 as profit-taking set in. This whipsaw behavior—large initial moves followed by significant reversals—is characteristic of BFLY's post-earnings trading.

The direction of Day 0 moves correlates strongly with earnings surprises. The Q3 2025 miss (-85.71% surprise) triggered a +31.86% Day 0 rally—counterintuitively positive, likely reflecting relief that losses weren't worse—followed by +8.18% continuation on Day +1. Conversely, the Q2 2025 beat produced a -18.13% Day 0 decline, suggesting guidance or forward commentary disappointed despite the earnings beat itself.

Day +1 follow-through averages 9.93% in absolute terms with a 15.14% range, indicating volatility persists well beyond the initial reaction. The February 2026 report's -18.84% Day +1 reversal after a massive Day 0 gain illustrates how quickly sentiment can shift. For the upcoming Q1 2026 report, investors should prepare for a potential ±16-20% swing on announcement day, with meaningful secondary moves likely on Day +1 as the market digests guidance and management commentary. The stock's low float and retail-heavy ownership base amplify these moves, making position sizing critical for risk management.

Part 2.2: Options Market Expected Move

The options market is pricing a 19.87% expected move through the May 15 expiration (16 days out), implying a range of $3.94 to $5.90. This expected move is slightly above the stock's average historical Day 0 move of 15.96% but in line with the 19.52% average Day 0 range, suggesting options traders are anticipating volatility consistent with BFLY's recent earnings history. The elevated implied volatility of 137.62% reflects the market's recognition of this stock's tendency for dramatic post-earnings swings.

Part 3: What Analysts Are Saying

Analysts maintain strong bullish conviction on Butterfly Network heading into earnings, with the consensus rating at 4.67 out of 5.0—firmly in Strong Buy territory. The breakdown shows 5 Strong Buys, 1 Hold, and zero Sell ratings among the 6 analysts covering the stock, reflecting broad agreement that BFLY's risk-reward profile favors the upside despite ongoing losses.

The average price target of $5.56 implies 13% upside from the current $4.92 price, with a tight range spanning from a low of $5.25 to a high of $6.00. This relatively narrow target band suggests analysts have converged on similar valuation frameworks, likely anchored to revenue multiples given the company's pre-profitability status. The $6.00 high target represents 22% upside potential, while even the most conservative $5.25 estimate offers 7% appreciation.

Sentiment has remained unchanged over the past month, with the 4.67 average rating and Strong Buy consensus holding steady. This stability follows a period of reassessment in mid-2025, when Oppenheimer downgraded BFLY from Outperform to Perform in August, citing concerns about the path to profitability. However, subsequent analyst initiations—including Craig Hallum's July 2025 Buy rating with a $3.00 target and William Blair's March 2025 Outperform rating—have reinforced the bullish thesis. The fact that no analysts have downgraded since Oppenheimer's move, despite the Q3 2025 earnings miss, suggests the Street views recent FDA clearances and strategic hires as validating the long-term opportunity. The unchanged sentiment heading into Q1 2026 earnings indicates analysts are comfortable with current expectations and see limited downside risk at these levels.

Part 4: Technical Picture

Butterfly Network enters earnings with exceptionally strong technical momentum, as the Barchart Technical Opinion registers a 100% Buy signal—up from 88% Buy a month ago. This strengthening conviction reflects the stock's sustained rally from the $2.98 level (200-day moving average) to the current $4.92, representing a 65% advance over the past six months. The signal has intensified from 100% Buy last week, indicating accelerating bullish pressure into the earnings event.

Timeframe Analysis:

• Short-term (100% Buy): Maximum bullish reading indicates powerful near-term momentum, with the stock breaking above key resistance levels and attracting aggressive buying ahead of earnings
• Medium-term (100% Buy): Sustained strength across the intermediate timeframe confirms this is not merely a short-term spike but a developing uptrend with institutional participation
• Long-term (100% Buy): The long-term signal reaching maximum bullishness suggests a potential regime change from the prior downtrend, with the stock establishing a new higher base

Trend Characteristics: The Strong and Strengthening trend environment heading into earnings creates a supportive backdrop for positive surprises while raising the bar for disappointment—any guidance miss could trigger sharp profit-taking given the extended rally.

The stock is trading above its 20-day ($4.78), 50-day ($4.17), 100-day ($3.96), and 200-day ($2.98) moving averages, confirming the uptrend across all major timeframes. However, BFLY sits below both its 5-day ($5.21) and 10-day ($5.32) moving averages, indicating a modest pullback from recent highs near $5.72 (the 52-week high). This short-term consolidation after a parabolic move may actually be healthy, reducing overbought conditions ahead of the earnings catalyst.

The technical setup is supportive but stretched. The 100% Buy signal and positioning above all major moving averages provide a bullish foundation, but the 65% rally from the 200-day average and proximity to 52-week highs mean the stock has limited cushion for disappointment. A beat-and-raise scenario could propel BFLY toward the $6.00 analyst high target, while any miss or cautious guidance risks a swift retest of the $4.17-$4.78 support zone where the 20-day and 50-day averages converge. Given the stock's history of extreme post-earnings volatility, the current technical strength favors bulls but demands tight risk management.